References Allocati N, Masulli M, Di llio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Understanding GLP-1 dosing: Starting low and titrating up All GLP-1 medications (glucagon-like peptide-1 receptor agonists) are initiated at a low dose and their dosage is gradually escalated over time to enhance your bodys tolerability and minimize the risk of side effects, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
If your vial is 5 mg/mL, 50 units delivers only 2.5 mg, which is the standard starting dose and is generally well-tolerated even by first-time users
Eric Topol (25:24): Yeah, I'm just citing the heart disease trial where in the New England Journal that point was made
It comprises a group of transcription factors linked to IBs inhibitor proteins and remains dormant in the cytoplasm